Predictors of Enrolment in a Transoral Surgical Trial for <scp>HPV</scp> ‐Related Oropharyngeal Carcinoma

OBJECTIVE: This study evaluated demographic, clinical and perceptual factors associated with enrolment in a Phase III transoral surgical trial for HPV-related oropharyngeal carcinoma. DESIGN: Single-centre, questionnaire-based cross-sectional pilot study of patients screened for PATHOS trial. SETTING: Tertiary cancer centre participating in the PATHOS trial. PARTICIPANTS: Patients with p16-positive oropharyngeal carcinoma were eligible for the trial. Of 100 patients screened, 70 met trial eligibility and 51 completed a telephone questionnaire and were included. Inability to complete the questionnaire because of cognitive impairment or a language barrier was a prespecified survey exclusion criterion. However, no patient was excluded for either reason. MAIN OUTCOME MEASURES: Primary outcome was the patient decision to enrol or decline participation in PATHOS (written consent). Predictor variables included demographic and clinical characteristics and responses to a 31-item Likert-scale questionnaire. RESULTS: Among 51 eligible patients who completed the questionnaire, 29 (57%) enroled in the trial. On univariable analysis, significant predictors included perceptions of treatment quality, toxicity, quality of life, travel distance, trial comprehension, randomisation, medical terminology, trust, prior trial experience and concern about being treated as a 'guinea pig'. On multivariable analysis, prior trial experience (p = 0.022) and not feeling like a 'guinea pig' (p = 0.047) remained significant, with travel distance trending (p = 0.087). CONCLUSIONS: Trial enrolment was driven primarily by prior exposure to clinical research and perceptions of vulnerability and trust, rather than by demographic or tumour factors. Addressing fears of being a 'guinea pig', improving trial comprehension and mitigating travel-related barriers may enhance accrual and promote more equitable participation in head and neck cancer trials.

Authors

Institutions

Publication Details

Journal
Clinical Otolaryngology
Published
2026-08-18
DOI
https://doi.org/10.1111/coa.70160
Primary Topic
Head and Neck Cancer Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Predictors of Enrolment in a Transoral Surgical Trial for HPV ‐Related Oropharyngeal Carcinoma

J. Scott Magnuson, Caroline Casey, Shravan Kandula, Bruce H. Haughey et al.
Clinical Otolaryngology
Head and Neck Cancer Studies
article

Predictors of Enrolment in a Transoral Surgical Trial for HPV ‐Related Oropharyngeal Carcinoma

J. Scott Magnuson, Caroline Casey, Shravan Kandula, Bruce H. Haughey, Andrea Costantino, Nina Gallo, Xiang Zhu, Tarek Mekhail
article en

Abstract

OBJECTIVE: This study evaluated demographic, clinical and perceptual factors associated with enrolment in a Phase III transoral surgical trial for HPV-related oropharyngeal carcinoma. DESIGN: Single-centre, questionnaire-based cross-sectional pilot study of patients screened for PATHOS trial. SETTING: Tertiary cancer centre participating in the PATHOS trial. PARTICIPANTS: Patients with p16-positive oropharyngeal carcinoma were eligible for the trial. Of 100 patients screened, 70 met trial eligibility and 51 completed a telephone questionnaire and were included. Inability to complete the questionnaire because of cognitive impairment or a language barrier was a prespecified survey exclusion criterion. However, no patient was excluded for either reason. MAIN OUTCOME MEASURES: Primary outcome was the patient decision to enrol or decline participation in PATHOS (written consent). Predictor variables included demographic and clinical characteristics and responses to a 31-item Likert-scale questionnaire. RESULTS: Among 51 eligible patients who completed the questionnaire, 29 (57%) enroled in the trial. On univariable analysis, significant predictors included perceptions of treatment quality, toxicity, quality of life, travel distance, trial comprehension, randomisation, medical terminology, trust, prior trial experience and concern about being treated as a 'guinea pig'. On multivariable analysis, prior trial experience (p = 0.022) and not feeling like a 'guinea pig' (p = 0.047) remained significant, with travel distance trending (p = 0.087). CONCLUSIONS: Trial enrolment was driven primarily by prior exposure to clinical research and perceptions of vulnerability and trust, rather than by demographic or tumour factors. Addressing fears of being a 'guinea pig', improving trial comprehension and mitigating travel-related barriers may enhance accrual and promote more equitable participation in head and neck cancer trials.

Clinical Otolaryngology
University of Central Florida (US), Hofstra University (US), University of Auckland (NZ), University of South Florida (US), AdventHealth Orlando (US), AdventHealth East Orlando (US), Florida Hospital Cancer Institute (US), IRCCS Humanitas Research Hospital (IT), Louisiana State University Health Sciences Center New Orleans (US), Florida College (US)
Reduced inequalities
Openalex Percentile: Top 7%
Head and Neck Cancer Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.